Maze Therapeutics (MAZE) Other Non-Current Assets (2024 - 2026)

Maze Therapeutics has reported Other Non-Current Assets for 3 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.09% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed 0.09% YoY) and the FY2025 annual result came in at $3.0 million, down 61.25% from the prior year.
• Other Non-Current Assets declined to $1.1 million in Q1 2026 per MAZE's latest filing, from $3.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $7.9 million in Q4 2024 and troughed at $1.1 million in Q1 2026.
• A 3-year average of $3.0 million and a median of $2.1 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets slumped 61.25% in 2025, then decreased 0.09% in 2026.
• Over 3 years, Other Non-Current Assets stood at $7.9 million in 2024, then plunged by 61.25% to $3.0 million in 2025, then sank by 64.3% to $1.1 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.1 million, $3.0 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.